Biopharmaceuticals
Drug Delivery
FDA
News Release - October 23, 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
Source: United Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.